Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

Authors :: Nakamura Y
Ratain MJ
Cox NJ
McLeod HL
Kroetz DL
Flockhart DA
Source :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2012 Aug 22; Vol. 104 (16), pp. 1264; author reply 1266-8. Date of Electronic Publication: 2012 Jul 31.
Publication Year :: 2012

Subjects :: Female
Humans
Antineoplastic Agents, Hormonal therapeutic use
Breast Neoplasms drug therapy
Breast Neoplasms enzymology
Breast Neoplasms epidemiology
Breast Neoplasms prevention & control
Cytochrome P-450 CYP2D6 genetics
Glucuronosyltransferase genetics
Neoplasm Recurrence, Local epidemiology
Neoplasm Recurrence, Local prevention & control
Nitriles therapeutic use
Polymorphism, Single Nucleotide
Postmenopause
Tamoxifen therapeutic use
Triazoles therapeutic use

Full Text Access

Tools